Top Premarket Decliners

MT Newswires Live2024-11-25

Oncternal Therapeutics (ONCT) shares tumbled 33% in recent Monday premarket activity after it said in a regulatory filing that Nasdaq believes the company is a "public shell" and will adopt more "stringent" criteria for its listing after its Nov. 14 announcement of workforce reduction.

Actuate Therapeutics (ACTU) stock fell 21%, extending Friday's loss.

Akoustis Technologies (AKTS) shares slipped 20%, continuing the previous session's loss.

Macy's (M) stock fell more than 3% after it reported preliminary fiscal Q3 results and said it was delaying its quarterly earnings release due to an "issue" it identified regarding delivery expenditures in one of its accrual accounts.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment